Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

Abstract

A 71 year old female with multiple myeloma presented with back pain seven year after autologous stem cell transplant. Skeletal bone survey and magnetic resonance imaging did not show a relapse that was evidenced by CT/PET. Lenalidomide as single agent induced a complete disappearance of the lesions 6 months later and confirmed after one year at CT/PET.

Keywords

• lenalidomide
• myeloma
• imaging